EMBL spin-off Velabs Therapeutics to cooperate with Chiome Bioscience in the field of GPCR-specific functional antibody screening EMBL spin-off Velabs Therapeutics to cooperate with Chiome Bioscience in the field of GPCR-specific functional antibody screening April 24, 2019 General Read more
Prioritising cancer drug targets using CRISPR Prioritising cancer drug targets using CRISPR April 11, 2019 General Read more
ATP affects proteome-wide solubility ATP affects proteome-wide solubility March 11, 2019 General Read more
Cell death trigger in tuberculosis bacteria Cell death trigger in tuberculosis bacteria February 19, 2019 General Read more
Almost 2000 unknown bacteria discovered in the human gut Almost 2000 unknown bacteria discovered in the human gut February 12, 2019 General Read more
New Open Targets Director appointed New Open Targets Director appointed January 23, 2019 General Read more
EMBL spin-out Velabs Therapeutics to Cooperate with BioMed X in the Field of Immunology EMBL spin-out Velabs Therapeutics to Cooperate with BioMed X in the Field of Immunology January 8, 2019 General Read more
